Age-wise trends in alkaline phosphatase activity in 167,625 Chinese children aged 0-18 years

Kui-Lin Lü1, Shuang-Shuang Xie2, En Liu3

  • 1Department of Pediatrics, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing 400037, PR China.

Clinical Biochemistry
|March 7, 2020
PubMed

Insights

Alkaline phosphatase (ALP) levels in children aged 0-18 show distinct age-related patterns, peaking earlier in girls and differing between Chinese and German populations. These findings establish crucial reference values for pediatric clinical use.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Clinical Chemistry

Background:

  • Alkaline phosphatase (ALP) is a key diagnostic biomarker in adults.
  • Pediatric ALP activity fluctuates significantly with age and physiological changes, limiting its diagnostic utility without age-specific reference values.

Purpose of the Study:

  • To investigate the age-specific dynamics of alkaline phosphatase (ALP) activity in children aged 0-18 years.
  • To establish reliable reference values for pediatric ALP activity.
  • To compare ALP activity patterns between Chinese and German children.

Main Methods:

  • Analysis of 167,625 pediatric samples (0-18 years).
  • ALP activity measured using the 4-nitrophenyl-1-phosphate disodium salt (4-NPP)-2-amino-2-methyl-1-propanol (AMP) method.
  • Percentile curves generated using MATLAB and fitted with the LMS method, excluding patients with conditions affecting ALP.

Main Results:

  • ALP activity peaks in boys aged 12-13 years and in girls aged 10-11 years.
  • Activity declines in both sexes through adolescence.
  • The peak ALP activity observed in Chinese children occurred earlier than in German children.

Conclusions:

  • The study elucidates the age-dependent dynamics of ALP activity in Chinese children (0-18 years).
  • Significant differences in ALP activity timing were noted between Chinese and German children.
  • Provides essential reference data for pediatric clinical interpretation of ALP levels.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
143
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
182
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
198
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
129